[Clinical Observation of Recombinant Bovine Basic Fibroblast Growth Factor as an Adjuvant Therapy for Patients with Atrophic Acne Scar].

Objective To study the influence of recombinant bovine basic fibroblast growth factor as an adjuvant therapy on scar alleviation and inflammatory cytokines in patients with atrophic acne scar. Methods The random number table was employed to randomly assign 120 patients with atrophic acne scar into a test group and a control group.Both groups of patients were treated with CO lattice laser.After the operation,the control group was routinely smeared with erythromycin ointment and the test group was coated with recombinant bovine basic fibroblast growth factor gel.The clinical efficacy,clinical indicators,scar alleviation,and inflammatory cytokine levels before and after treatment were compared,and adverse reactions were counted. Results The test group had higher total effective rate(=0.040) and lower total incidence of adverse reactions(=0.028) than the control group.Compared with the control group,the test group showcased short erythema duration after treatment(=0.025),early scab forming(=0.002),and early edema regression(<0.001).After treatment,the proportion of grade 1 scars graded by Goodman and Baron's acne scar grading system in the test group and control group increased(=0.001,=0.027),and the proportion of grade 4 scars decreased(<0.001,=0.034).Moreover,the proportion of grade 1 scars in the test group was higher than that in the control group(=0.031) after treatment,and the proportion of grade 4 scars presented an opposite trend(=0.031).After treatment,the levels of tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) in both groups declined(all <0.001),and the test group had lower TNF-α and IL-1β levels than the control group(all <0.001). Conclusion The recombinant bovine basic fibroblast growth factor gel as an adjuvant therapy of CO lattice laser can effectively alleviate the atrophic acne scar,relieve local inflammatory reaction,and has good curative effect and less adverse reactions.